Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.20.1
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Revenue, Major Customer [Line Items]        
Revenues $ 9,943,104 $ 6,976,115 $ 20,521,120 $ 13,347,924
FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 9,522,271 6,843,923 19,947,195 13,168,320
PREBOOST Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 420,833 132,192 573,925 179,604
Public Sector [Member] | FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 2,569,644 4,249,652 6,943,438 8,134,004
U.S. Prescription Channel Segment [Member] | FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues $ 6,952,627 $ 2,594,271 $ 13,003,757 $ 5,034,316